1. Home
  2. MDXG vs BRBI Comparison

MDXG vs BRBI Comparison

Compare MDXG & BRBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDXG
  • BRBI
  • Stock Information
  • Founded
  • MDXG 2006
  • BRBI 2009
  • Country
  • MDXG United States
  • BRBI Brazil
  • Employees
  • MDXG N/A
  • BRBI N/A
  • Industry
  • MDXG Biotechnology: Pharmaceutical Preparations
  • BRBI Finance: Consumer Services
  • Sector
  • MDXG Health Care
  • BRBI Finance
  • Exchange
  • MDXG Nasdaq
  • BRBI Nasdaq
  • Market Cap
  • MDXG 1.0B
  • BRBI 1.2B
  • IPO Year
  • MDXG N/A
  • BRBI N/A
  • Fundamental
  • Price
  • MDXG $7.12
  • BRBI $15.41
  • Analyst Decision
  • MDXG Buy
  • BRBI
  • Analyst Count
  • MDXG 1
  • BRBI 0
  • Target Price
  • MDXG $12.00
  • BRBI N/A
  • AVG Volume (30 Days)
  • MDXG 1.2M
  • BRBI 19.9K
  • Earning Date
  • MDXG 10-29-2025
  • BRBI 11-07-2025
  • Dividend Yield
  • MDXG N/A
  • BRBI N/A
  • EPS Growth
  • MDXG N/A
  • BRBI N/A
  • EPS
  • MDXG 0.27
  • BRBI 0.31
  • Revenue
  • MDXG $393,442,000.00
  • BRBI N/A
  • Revenue This Year
  • MDXG $19.01
  • BRBI N/A
  • Revenue Next Year
  • MDXG $2.36
  • BRBI $29.31
  • P/E Ratio
  • MDXG $26.29
  • BRBI $12.86
  • Revenue Growth
  • MDXG 14.77
  • BRBI N/A
  • 52 Week Low
  • MDXG $5.79
  • BRBI $12.15
  • 52 Week High
  • MDXG $10.14
  • BRBI $67.01
  • Technical
  • Relative Strength Index (RSI)
  • MDXG 46.92
  • BRBI N/A
  • Support Level
  • MDXG $7.23
  • BRBI N/A
  • Resistance Level
  • MDXG $7.63
  • BRBI N/A
  • Average True Range (ATR)
  • MDXG 0.41
  • BRBI 0.00
  • MACD
  • MDXG -0.03
  • BRBI 0.00
  • Stochastic Oscillator
  • MDXG 29.68
  • BRBI 0.00

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

About BRBI BRBI BR Partners S.A. ADSs

BRBI BR Partners SA, formerly BR Advisory Partners Participacoes SA, is engaged in investing in other companies, domestic or foreign, as a partner, quota holder, or shareholder, and management of its assets. It has a single reportable segment being investment banking services, which are administered and managed according to the products offered.

Share on Social Networks: